被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Singapore: HSA updates on products found overseas that contain potent ingredients (Jan 2023) (English only) |
| |
The Health Sciences Authority (HSA) would like to update the public on products that have been found and reported by overseas regulators in Jan 2023 to contain potent ingredients which are not allowed in these products and may cause side effects. This information is provided to increase awareness on safety issues of such products found overseas, which may impact the local population.
There are 20 affected products listed in this announcement. For details of the affected products, please refer to the website in HSA.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/safety-alert/hsa-updates-on-products-found-overseas-that-contain-potent-ingredients-(january-2023)
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by the United States Food and Drug Administration and Health Canada, and was posted on the Drug Office website on 16 Jul 2022, 11 Nov 2022, 21 Jan 2023 and 26 Jan 2023.
Ends/Wednesday, Feb 8, 2023
Issued at HKT 15:00
|
| |
